on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech publishes its 2024 Universal Registration Document
Sartorius Stedim Biotech, a major player in the biopharmaceutical industry, has announced the publication of its 2024 Universal Registration Document, which includes the annual financial report. This document is available on their website.
Sartorius' financial calendar includes several key dates in 2025: the Annual General Meeting on March 25 and the publication of quarterly and half-year financial results through October.
Sartorius generated sales of €2.8 billion in 2024 and employs more than 9,900 people worldwide. The company continues to expand its business portfolio through the acquisition of new technologies.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news